vs
APOGEE ENTERPRISES, INC.（APOG）とPrivia Health Group, Inc.（PRVA）の財務データ比較。上の社名をクリックして会社を切り替えられます
Privia Health Group, Inc.の直近四半期売上が大きい（$603.8M vs $351.4M、APOGEE ENTERPRISES, INC.の約1.7倍）。APOGEE ENTERPRISES, INC.の純利益率が高く（4.7% vs 0.6%、差は4.1%）。Privia Health Group, Inc.の前年同期比売上増加率が高い（25.8% vs 1.6%）。過去8四半期でPrivia Health Group, Inc.の売上複合成長率が高い（19.6% vs 2.9%）
Apogee Enterprisesはアメリカのオーディオ機器メーカーです。オーディオインターフェース、AD/DAコンバーター、USB・iOS対応マイクの製造を主軸に、オーディオ制作向けソフトウェアの開発も手がけており、プロの録音や音楽制作分野で広く利用されています。
Privia Health Group, Inc.は米国に本拠を置く医療テクノロジー・サービス企業で、独立診療所、医療システム、保険者向けに価値基準型医療の実践を支援します。人口健康管理ツール、患者エンゲージメント基盤、ケア調整支援、業務フロー最適化ソリューションを提供し、診療成果の向上と運用コスト削減を促します。
APOG vs PRVA — 直接比較
損益計算書 — Q4 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $351.4M | $603.8M |
| 純利益 | $16.6M | $3.7M |
| 粗利率 | 22.4% | 20.8% |
| 営業利益率 | 7.3% | 1.2% |
| 純利益率 | 4.7% | 0.6% |
| 売上前年比 | 1.6% | 25.8% |
| 純利益前年比 | 568.8% | -27.4% |
| EPS（希薄化後） | $0.78 | $0.02 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $351.4M | $603.8M | ||
| Q4 25 | $348.6M | $541.2M | ||
| Q3 25 | $358.2M | $580.4M | ||
| Q2 25 | $346.6M | $521.2M | ||
| Q1 25 | $345.7M | $480.1M | ||
| Q4 24 | $341.3M | $460.9M | ||
| Q3 24 | $342.4M | $437.9M | ||
| Q2 24 | $331.5M | $422.3M |
| Q1 26 | $16.6M | $3.7M | ||
| Q4 25 | $16.5M | $9.2M | ||
| Q3 25 | $23.6M | $6.9M | ||
| Q2 25 | $-2.7M | $2.7M | ||
| Q1 25 | $2.5M | $4.2M | ||
| Q4 24 | $21.0M | $4.4M | ||
| Q3 24 | $30.6M | $3.5M | ||
| Q2 24 | $31.0M | $3.5M |
| Q1 26 | 22.4% | 20.8% | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 29.8% | — |
| Q1 26 | 7.3% | 1.2% | ||
| Q4 25 | 7.1% | 2.1% | ||
| Q3 25 | 7.5% | 2.5% | ||
| Q2 25 | 2.0% | 0.6% | ||
| Q1 25 | 1.8% | 1.1% | ||
| Q4 24 | 8.4% | 1.1% | ||
| Q3 24 | 12.3% | 1.3% | ||
| Q2 24 | 12.5% | 1.2% |
| Q1 26 | 4.7% | 0.6% | ||
| Q4 25 | 4.7% | 1.7% | ||
| Q3 25 | 6.6% | 1.2% | ||
| Q2 25 | -0.8% | 0.5% | ||
| Q1 25 | 0.7% | 0.9% | ||
| Q4 24 | 6.1% | 1.0% | ||
| Q3 24 | 8.9% | 0.8% | ||
| Q2 24 | 9.4% | 0.8% |
| Q1 26 | $0.78 | $0.02 | ||
| Q4 25 | $0.77 | $0.08 | ||
| Q3 25 | $1.10 | $0.05 | ||
| Q2 25 | $-0.13 | $0.02 | ||
| Q1 25 | $0.12 | $0.03 | ||
| Q4 24 | $0.96 | $0.03 | ||
| Q3 24 | $1.40 | $0.03 | ||
| Q2 24 | $1.41 | $0.03 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $39.5M | $419.5M |
| 総負債低いほど良い | $232.3M | — |
| 株主資本純資産 | $511.8M | $805.9M |
| 総資産 | $1.1B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.45× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $39.5M | $419.5M | ||
| Q4 25 | $41.3M | $479.7M | ||
| Q3 25 | $39.5M | $441.4M | ||
| Q2 25 | $32.8M | $390.1M | ||
| Q1 25 | $41.4M | $469.3M | ||
| Q4 24 | $43.9M | $491.1M | ||
| Q3 24 | $51.0M | $422.0M | ||
| Q2 24 | $30.4M | $387.4M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $511.8M | $805.9M | ||
| Q4 25 | $512.3M | $737.2M | ||
| Q3 25 | $500.2M | $709.1M | ||
| Q2 25 | $481.8M | $682.9M | ||
| Q1 25 | $487.9M | $659.4M | ||
| Q4 24 | $522.1M | $635.2M | ||
| Q3 24 | $506.4M | $614.9M | ||
| Q2 24 | $480.0M | $595.4M |
| Q1 26 | $1.1B | $1.4B | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $917.1M | $1.1B | ||
| Q2 24 | $889.0M | $1.1B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $122.5M | $-49.5M |
| フリーキャッシュフロー営業CF - 設備投資 | — | — |
| FCFマージンFCF / 売上 | — | — |
| 設備投資強度設備投資 / 売上 | 7.8% | — |
| キャッシュ転換率営業CF / 純利益 | 7.37× | -13.33× |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $122.5M | $-49.5M | ||
| Q4 25 | $29.3M | $127.5M | ||
| Q3 25 | $57.1M | $52.0M | ||
| Q2 25 | $-19.8M | $8.0M | ||
| Q1 25 | $30.0M | $-24.1M | ||
| Q4 24 | $31.0M | $74.8M | ||
| Q3 24 | $58.7M | $33.2M | ||
| Q2 24 | $5.5M | $34.5M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $52.4M | — | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $50.2M | — | ||
| Q2 24 | $-1.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 14.6% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | -0.5% | — |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.2% | — |
| Q1 26 | 7.37× | -13.33× | ||
| Q4 25 | 1.77× | 13.93× | ||
| Q3 25 | 2.41× | 7.58× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | 12.08× | -5.70× | ||
| Q4 24 | 1.48× | 17.00× | ||
| Q3 24 | 1.92× | 9.38× | ||
| Q2 24 | 0.18× | 9.94× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
PRVA
| FFS-patient care | $391.1M | 65% |
| Capitated revenue | $86.1M | 14% |
| Other | $75.0M | 12% |
| FFS-administrative services | $31.4M | 5% |
| Care management fees (PMPM) | $17.9M | 3% |
| Other revenue | $2.3M | 0% |
